is an american molecular diagnostic company based in salt lake city utah united states myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset progression and treatment of disease this information is used to guide the development of new molecular diagnostic products that assess an individual s risk for developing disease later in life predictive medicine identify a patient s likelihood of responding to a particular drug therapy personalized medicine assess a patient s risk of disease progression and disease recurrence personalized medicine and measure disease activity myriad s discovery of the breast cancer gene brca1 was universally acclaimed as a monumental achievement there is no more exciting story in medical science myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices which led to the landmark supreme court decision association for molecular pathology v myriad genetics inc in august 2016 myriad announced it would acquire assurex health for up to 410million expanding the company s genetic testing for psychotropic medicine selection in july 2018 myriad completed an acquisition of reproductive genetic testing firm